Therefore, even if R. mucosa is unlikely to specifically modulate each of the immunologic pathways that distinguish the AD and psoriasis, modulation of TNF signalling along with increased ceramide-family lipids would be expected to provide utility to any inflammatory skin disease. The gene discussed is TNF; the disease is psoriasis.